Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peleven AG is an active Swiss-based engineering consultancy founded in February 2020 that provides specialized project management and technical consulting services to the pharmaceutical, biotechnology, and chemical research sectors. Their core offerings include supporting investment projects from feasibility through commissioning with expertise tailored for highly regulated life science industries. They do not develop their own therapeutics nor operate as a CRO/CDMO but are integral partners for companies seeking efficient facility builds or upgrades within these fields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peleven.